Similar articles

• Comparison of enzyme-linked immunosorbent assay and radioimmunoassay for prostate-specific acid phosphatase in prostatic disease.

  Griffiths J, Rippe DF, Panfili PR. Griffiths J, et al. Clin Chem. 1982 Jan;28(1):183-6. Clin Chem. 1982. PMID: 7055908
• The appropriate uses of prostatic acid phosphatase determination in the diagnosis of adenocarcinoma of the prostate.

  Griffiths J. Griffiths J. Ann N Y Acad Sci. 1982;390:100-3. doi: 10.1111/j.1749-6632.1982.tb40307.x. Ann N Y Acad Sci. 1982. PMID: 6953922 No abstract available.
• [New prospective diagnostic serum markers in prostatic cancer].

  Mirone V, De Bellis G, Prezioso D, Sanseverino R, Iannucci F, Padulano P. Mirone V, et al. Minerva Med. 1986 Mar 31;77(13):503-4. Minerva Med. 1986. PMID: 2422605 Italian. No abstract available.
• Prostatic acid phosphatase: its current clinical status.

  Heller JE. Heller JE. J Urol. 1987 Jun;137(6):1091-103. doi: 10.1016/s0022-5347(17)44414-4. J Urol. 1987. PMID: 3295298 Review. No abstract available.
• Enzyme measurements by mass: an interim review of the clinical efficacy of some mass measurements of prostatic acid phosphatase and isoenzymes of creatine kinase.

  Henderson AR, Nealon DA. Henderson AR, et al. Clin Chim Acta. 1981;115(1):9-32. doi: 10.1016/0009-8981(81)90103-0. Clin Chim Acta. 1981. PMID: 7021004 Review. No abstract available.